ROMAGNOLI, Dante
 Distribuzione geografica
Continente #
NA - Nord America 4.636
EU - Europa 2.042
AS - Asia 2.023
SA - Sud America 273
Continente sconosciuto - Info sul continente non disponibili 79
AF - Africa 56
OC - Oceania 29
Totale 9.138
Nazione #
US - Stati Uniti d'America 4.557
SG - Singapore 662
CN - Cina 526
GB - Regno Unito 427
IT - Italia 388
PL - Polonia 239
HK - Hong Kong 217
DE - Germania 207
VN - Vietnam 202
BR - Brasile 199
FI - Finlandia 195
SE - Svezia 164
BD - Bangladesh 99
RU - Federazione Russa 99
FR - Francia 94
UA - Ucraina 63
IN - India 51
TR - Turchia 51
ID - Indonesia 42
CA - Canada 38
KR - Corea 35
BG - Bulgaria 31
AR - Argentina 30
JP - Giappone 29
AU - Australia 27
LT - Lituania 26
NL - Olanda 22
MX - Messico 20
IQ - Iraq 17
EG - Egitto 15
ZA - Sudafrica 15
EC - Ecuador 11
ES - Italia 11
AT - Austria 10
BE - Belgio 10
GR - Grecia 10
PK - Pakistan 10
IE - Irlanda 9
MY - Malesia 9
SA - Arabia Saudita 9
SI - Slovenia 8
CO - Colombia 7
PE - Perù 7
PH - Filippine 7
CZ - Repubblica Ceca 6
JO - Giordania 6
MA - Marocco 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BH - Bahrain 5
EU - Europa 5
UY - Uruguay 5
CL - Cile 4
DZ - Algeria 4
GT - Guatemala 4
NP - Nepal 4
TH - Thailandia 4
VE - Venezuela 4
BO - Bolivia 3
CH - Svizzera 3
DK - Danimarca 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PY - Paraguay 3
SV - El Salvador 3
TW - Taiwan 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
GE - Georgia 2
KG - Kirghizistan 2
MN - Mongolia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TN - Tunisia 2
UG - Uganda 2
AL - Albania 1
BB - Barbados 1
BM - Bermuda 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
Totale 9.055
Città #
Fairfield 505
Ashburn 489
Singapore 465
Santa Clara 396
Woodbridge 295
Chandler 252
Seattle 246
Southend 246
Houston 243
Warsaw 237
Hong Kong 209
Wilmington 187
Helsinki 182
San Jose 171
Cambridge 153
Dearborn 123
Nyköping 123
Council Bluffs 118
Ann Arbor 99
Hefei 94
Modena 89
New York 87
Beijing 85
London 85
Jacksonville 77
Ho Chi Minh City 59
Los Angeles 58
Hanoi 57
The Dalles 52
Chicago 39
Shanghai 39
Lauterbourg 36
San Diego 35
Seoul 33
Izmir 32
Milan 32
Sofia 29
Jakarta 26
Princeton 26
Eugene 25
Moscow 25
Munich 21
Buffalo 20
Guangzhou 20
Frankfurt am Main 19
Melbourne 19
Phoenix 18
São Paulo 18
Dallas 17
Salt Lake City 16
Boardman 15
Tokyo 15
Denver 14
Redwood City 14
Rome 14
Atlanta 13
Bologna 12
Orem 12
Da Nang 11
Redondo Beach 11
Athens 10
Dong Ket 10
Fremont 10
San Mateo 10
Stockholm 10
Amsterdam 9
Bremen 9
Brussels 9
Chennai 9
Dublin 9
Florence 9
Johannesburg 9
Manchester 9
Schiffdorf 9
Haiphong 8
Mexico City 8
Miano 8
Padova 8
Palisades Park 8
Toronto 8
Boston 7
Carpi 7
Nanjing 7
Naples 7
Semarang 7
Amman 6
Brno 6
Dhaka 6
Montreal 6
Paris 6
Portsmouth 6
Shibīn al Kawm 6
Charlotte 5
Columbus 5
Curitiba 5
Gifu 5
Grafing 5
Kent 5
Lima 5
Mumbai 5
Totale 6.454
Nome #
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 497
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 459
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 392
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 375
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 370
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 369
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 340
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 339
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 339
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 325
Nonalcoholic fatty liver disease and aging: epidemiology to management 322
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 317
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 301
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 295
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 276
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 275
Alcohol and Steatosis: The Japanese Paradox 275
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 274
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in Italy 262
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 252
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy 250
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 239
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 231
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 229
Gender differences in chronic alcoholic and viral liver diseases 213
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 210
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 199
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 192
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 179
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy 171
Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target 167
Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma 160
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 44
Totale 9.138
Categoria #
all - tutte 35.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022477 0 51 19 20 14 37 25 28 68 46 119 50
2022/2023683 68 90 61 77 66 76 15 72 75 9 32 42
2023/2024451 22 33 56 31 69 47 17 35 19 7 49 66
2024/20251.417 28 11 38 101 294 207 108 97 154 62 139 178
2025/20263.215 193 123 199 270 395 499 411 142 341 290 185 167
2026/2027126 103 23 0 0 0 0 0 0 0 0 0 0
Totale 9.138